Motor Cortex Stimulation for Facial Pain.
Journal
Progress in neurological surgery
ISSN: 1662-3924
Titre abrégé: Prog Neurol Surg
Pays: Switzerland
ID NLM: 0076033
Informations de publication
Date de publication:
2020
2020
Historique:
received:
04
07
2020
accepted:
04
07
2020
pubmed:
30
9
2020
medline:
15
9
2021
entrez:
29
9
2020
Statut:
ppublish
Résumé
Motor cortex stimulation (MCS) has been used in the treatment of intractable neuropathic facial pain for nearly 30 years. While efficacy rates have been noted as high as 88% in some studies, considerable variability in treatment response remains. Additionally, MCS is often cited as providing diminishing relief over time, and there are few long-term studies on efficacy. Complications are generally mild and include infection, hardware complication, seizure, and transient neurological deficit. Despite relatively minimal use, MCS remains a viable treatment option for the appropriately selected facial pain patients that have proved refractory to conservative management.
Identifiants
pubmed: 32992322
pii: 000509909
doi: 10.1159/000509909
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
162-169Informations de copyright
© 2020 S. Karger AG, Basel.